31 Complications in the Post-Operative Period Following Adrenalectomy for Phaeochromocytoma
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.118 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von B Stevens.
Abstract (Originalsprache)
Introduction
Phaeochromocytomas are rare tumours made of chromaffin cells which are responsible for producing catecholamines in the adrenal medulla. In this context, a prolonged sympathetic response ensues, causing clinical features such as hypertension. When a phaeochromocytoma is resected, the biochemistry of the body is significantly altered, sometimes resulting in profound hypotension and hypoglycaemia. For this reason, current best practice recommends admission to HDU/ITU following adrenalectomy for phaeochromocytoma.
Method
A regional database was created to include retrospective patients from 2022 – 2024 who underwent phaeochromocytoma removal. The database included demographics, preoperative/perioperative/postoperative data, and histology. Data were segregated by the stages of patient journey, from initial referral and assessments by surgical and anaesthetic teams, to operation notes and post-operative clinic letters.
Results
Twenty-one patients underwent adrenalectomy for phaeochromocytoma in the 2022-2024 timeframe. Of these, only two patients experienced an episode of hypoglycaemia requiring IV glucose, and one had an episode of postoperative hypotension requiring vasopressors.
Conclusions
These data suggest that the incidence of profound hypotension in this cohort of patients is lower than previously thought, and that adrenalectomy for phaeochromocytoma may not de facto indicate HDU/ITU admission. Similarly, while these patients should have careful glucose monitoring in the post-operative period, both this monitoring as well as management of hypoglycaemia can typically be carried out in a ward setting. Next steps could involve exploring risk factors which predispose this patient cohort to complications, such as diabetes.
Zitieren
APA
Stevens, B. (2026). 31 Complications in the Post-Operative Period Following Adrenalectomy for Phaeochromocytoma. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.118
Vancouver
Stevens B. 31 Complications in the Post-Operative Period Following Adrenalectomy for Phaeochromocytoma. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.118
BibTeX
@article{Stevens2026,
author = {Stevens, B},
title = {31 Complications in the Post-Operative Period Following Adrenalectomy for Phaeochromocytoma},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.118}
}
EUVIMED